Oncternal Therapeutics Inc
(ONCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 82,159 | 90,765 | 97,380 | 103,663 | 111,211 |
| TOTAL | $85,066 | $92,853 | $99,520 | $107,599 | $113,084 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 422 | 732 | 776 | 820 | 973 |
| TOTAL | $422 | $732 | $776 | $820 | $973 |
| Total Assets | $85,488 | $93,585 | $100,296 | $108,419 | $114,057 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,395 | 1,959 | 2,746 | 1,009 | 1,892 |
| Accrued Expenses | 2,868 | 3,431 | 2,797 | 2,493 | 2,773 |
| TOTAL | $5,294 | $5,465 | $5,820 | $5,900 | $5,723 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 158 | 2,236 | 885 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 31 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $31 |
| Total Liabilities | $5,294 | $5,465 | $5,820 | $5,900 | $5,754 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,471 | 2,471 | 2,471 | 2,469 | 2,468 |
| Common Shares | 49 | 49 | 49 | 49 | 49 |
| Retained earnings | -124,034 | -114,130 | -106,057 | -96,427 | -88,745 |
| TOTAL | $80,194 | $88,120 | $94,476 | $102,519 | $108,303 |
| Total Liabilities And Equity | $85,488 | $93,585 | $100,296 | $108,419 | $114,057 |